Arteriosclerosis and Thrombosis, Vol 14, 1056-1065, Copyright © 1994 by American Heart Association
ARTICLES |
M de la Llera Moya, V Atger, JL Paul, N Fournier, N Moatti, P Giral, KE Friday and G Rothblat
Department of Biochemistry, Medical College of Pennsylvania, Philadelphia 19129.
A cell culture system was employed to test a large number of samples of human serum for the ability to stimulate the efflux of cell cholesterol. The extent of efflux obtained with each specimen was correlated with the serum concentrations of cholesterol, triglycerides, apoprotein (apo) B, apo A-I, apo A-II, and lipoprotein subfractions (ie, high-density lipoprotein2 [HDL2], HDL3, lipoprotein [Lp] A-I, and LpA-I:A-II). In addition, the subsequent esterification of the released cholesterol and the distribution of the synthesized exogenous cholesteryl esters between HDL and low-density lipoprotein/very-low- density lipoprotein provided estimates of the lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) activities of each serum. The values for these activities were analyzed for correlations with cell efflux and the various serum parameters. Cell cholesterol efflux best correlated with serum total HDL cholesterol values. HDL2 and HDL3 correlated about equally well with efflux, whereas LpA-I demonstrated a much greater association with efflux than did LpA-I:A-II. Analysis of the data by partial correlation analysis indicated that HDL3 and LpA-I were the HDL subfractions most closely associated with efflux. Esterification of the released radiolabeled cholesterol was strongly and positively correlated with serum triglyceride concentrations and negatively related to the serum concentrations of HDL2. There was no relation between esterification values, which reflect LCAT activity, and efflux. The transfer of the labeled cholesteryl esters between HDL and apoB-containing lipoproteins was used as a measure of CETP activity and demonstrated a pattern in which all apoB-related parameters were positively correlated to transfer of esterified cholesterol, and all HDL associated parameters, particularly HDL3, were negatively related to transfer. No relations were observed between efflux, esterification, and transfer.
This article has been cited by other articles:
![]() |
E. T. Alexander, G. L. Weibel, M. R. Joshi, C. Vedhachalam, M. de la Llera-Moya, G. H. Rothblat, M. C. Phillips, and D. J. Rader Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1496 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Sacks, L. L. Rudel, A. Conner, H. Akeefe, G. Kostner, T. Baki, G. Rothblat, M. de la Llera-Moya, B. Asztalos, T. Perlman, et al. Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo J. Lipid Res., May 1, 2009; 50(5): 894 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kralova Lesna, P. Suchanek, J. Kovar, P. Stavek, and R. Poledne Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport J. Lipid Res., November 1, 2008; 49(11): 2414 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. deGoma, R. L. deGoma, and D. J. Rader Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2199 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects J. Lipid Res., March 1, 2008; 49(3): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Weibel, E. T. Alexander, M. R. Joshi, D. J. Rader, S. Lund-Katz, M. C. Phillips, and G. H. Rothblat Wild-Type ApoA-I and the Milano Variant Have Similar Abilities to Stimulate Cellular Lipid Mobilization and Efflux Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 2022 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Qu, G. Perdomo, D. Su, F. M. D'Souza, N. S. Shachter, and H. H. Dong Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice J. Lipid Res., July 1, 2007; 48(7): 1476 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Ng, N. Bourquard, S. Y. Hama, D. Shih, V. R. Grijalva, M. Navab, A. M. Fogelman, and S. T. Reddy Adenovirus-Mediated Expression of Human Paraoxonase 3 Protects Against the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1368 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Favari, M. Gomaraschi, I. Zanotti, F. Bernini, M. Lee-Rueckert, P. T. Kovanen, C. R. Sirtori, G. Franceschini, and L. Calabresi A Unique Protease-sensitive High Density Lipoprotein Particle Containing the Apolipoprotein A-IMilano Dimer Effectively Promotes ATP-binding Cassette A1-mediated Cell Cholesterol Efflux J. Biol. Chem., February 23, 2007; 282(8): 5125 - 5132. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mezdour, G. Larigauderie, G. Castro, G. Torpier, J. Fruchart, M. Nowak, J.-C. Fruchart, M. Rouis, and N. Maeda Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency J. Lipid Res., May 1, 2006; 47(5): 912 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 706 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zimetti, G. K. Weibel, M. Duong, and G. H. Rothblat Measurement of cholesterol bidirectional flux between cells and lipoproteins J. Lipid Res., March 1, 2006; 47(3): 605 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsuyama, N. Sakai, H. Hiraoka, K.-i. Hirano, and S. Yamashita Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages J. Lipid Res., January 1, 2006; 47(1): 78 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Chirinos, J. P. Zambrano, S. Chakko, A. Schob, R. B. Goldberg, G. Perez, and A. J. Mendez Ability of Serum to Decrease Cellular AcylCoA:Cholesterol Acyl Transferase Activity Predicts Cardiovascular Outcomes Circulation, October 18, 2005; 112(16): 2446 - 2453. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Yancey, B. F. Asztalos, N. Stettler, D. Piccoli, D. L. Williams, M. A. Connelly, and G. H. Rothblat SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome J. Lipid Res., September 1, 2004; 45(9): 1724 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. J. Beulens, A. Sierksma, A. van Tol, N. Fournier, T. van Gent, J-L. Paul, and H. F. J. Hendriks Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1 J. Lipid Res., September 1, 2004; 45(9): 1716 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Yancey, M.-a. Kawashiri, R. Moore, J. M. Glick, D. L. Williams, M. A. Connelly, D. J. Rader, and G. H. Rothblat In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux J. Lipid Res., February 1, 2004; 45(2): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Schmid, W. S. Davidson, L. Myatt, and L. A. Woollett Transport of cholesterol across a BeWo cell monolayer: implications for net transport of sterol from maternal to fetal circulation J. Lipid Res., October 1, 2003; 44(10): 1909 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guerin, W. Le Goff, E. Frisdal, S. Schneider, D. Milosavljevic, E. Bruckert, and M. J. Chapman Action of Ciprofibrate in Type IIB Hyperlipoproteinemia: Modulation of the Atherogenic Lipoprotein Phenotype and Stimulation of High-Density Lipoprotein-Mediated Cellular Cholesterol Efflux J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3738 - 3746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Forrester Prevention of Plaque Rupture: A New Paradigm of Therapy Ann Intern Med, November 19, 2002; 137(10): 823 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guerin, P. Egger, C. Soudant, W. Le Goff, A. van Tol, R. Dupuis, and M. J. Chapman Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state J. Lipid Res., October 1, 2002; 43(10): 1652 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fournier, A. Cogny, V. Atger, D. Pastier, D. Goudouneche, A. Nicoletti, N. Moatti, J. Chambaz, J.-L. Paul, and A.-D. Kalopissis Opposite Effects of Plasma From Human Apolipoprotein A-II Transgenic Mice on Cholesterol Efflux From J774 Macrophages and Fu5AH Hepatoma Cells Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 638 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Montoya, A. Porres, S. Serrano, J. C. Fruchart, P. Mata, J. A. G. Gerique, and G. R. Castro Fatty acid saturation of the diet and plasma lipid concentrations, lipoprotein particle concentrations, and cholesterol efflux capacity Am. J. Clinical Nutrition, March 1, 2002; 75(3): 484 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Martin-Campos, J. Julve, J. C. Escola, J. Ordonez-Llanos, J. Gomez, J. Binimelis, F. Gonzalez-Sastre, and F. Blanco-Vaca ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia J. Lipid Res., January 1, 2002; 43(1): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. van der Gaag, A. van Tol, S. H. F. Vermunt, L. M. Scheek, G. Schaafsma, and H. F. J. Hendriks Alcohol consumption stimulates early steps in reverse cholesterol transport J. Lipid Res., December 1, 2001; 42(12): 2077 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Shah, J. Yano, O. Reyes, K.-Y. Chyu, S. Kaul, C. L. Bisgaier, S. Drake, and B. Cercek High-Dose Recombinant Apolipoprotein A-IMilano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E-Deficient Mice : Potential Implications for Acute Plaque Stabilization Circulation, June 26, 2001; 103(25): 3047 - 3050. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Van Lenten, A. C. Wagner, D. P. Nayak, S. Hama, M. Navab, and A. M. Fogelman High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection Circulation, May 8, 2001; 103(18): 2283 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tailleux, M. Bouly, G. Luc, G. Castro, J.-M. Caillaud, N. Hennuyer, P. Poulain, J.-C. Fruchart, N. Duverger, and C. Fievet Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice Arterioscler Thromb Vasc Biol, November 1, 2000; 20(11): 2453 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Dhaliwal and U. P. Steinbrecher Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally J. Lipid Res., October 1, 2000; 41(10): 1658 - 1665. [Abstract] [Full Text] |
||||
![]() |
N. Fournier, V. Atger, J.-L. Paul, M. Sturm, N. Duverger, G. H. Rothblat, and N. Moatti Human ApoA-IV Overexpression in Transgenic Mice Induces cAMP-Stimulated Cholesterol Efflux From J774 Macrophages to Whole Serum Arterioscler Thromb Vasc Biol, May 1, 2000; 20(5): 1283 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Christian, H.-S. Byun, N. Zhong, M. Wanunu, T. Marti, A. Fürer, F. Diederich, R. Bittman, and G. H. Rothblat Comparison of the capacity of {beta}-cyclodextrin derivatives and cyclophanes to shuttle cholesterol between cells and serum lipoproteins J. Lipid Res., August 1, 1999; 40(8): 1475 - 1482. [Abstract] [Full Text] |
||||
![]() |
G. H. Rothblat, M. de la Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips Cell cholesterol efflux: integration of old and new observations provides new insights J. Lipid Res., May 1, 1999; 40(5): 781 - 796. [Abstract] [Full Text] |
||||
![]() |
G. Franceschini, L. Calabresi, G. Chiesa, C. Parolini, C. R. Sirtori, M. Canavesi, and F. Bernini Increased Cholesterol Efflux Potential of Sera From ApoA-IMilano Carriers and Transgenic Mice Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1257 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. de la Llera-Moya, G. H. Rothblat, M. A. Connelly, G. Kellner-Weibel, S. W. Sakr, M. C. Phillips, and D. L. Williams Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface J. Lipid Res., March 1, 1999; 40(3): 575 - 580. [Abstract] [Full Text] |
||||
![]() |
A. Davit-Spraul, V. Atger, M. L. Pourci, M. Hadchouel, A. Legrand, and N. Moatti Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome: importance of the HDL-phospholipids/free cholesterol ratio and of the HDL size distribution J. Lipid Res., February 1, 1999; 40(2): 328 - 335. [Abstract] [Full Text] |
||||
![]() |
P. W. Baker, K.-A. Rye, J. R. Gamble, M. A. Vadas, and P. J. Barter Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells J. Lipid Res., February 1, 1999; 40(2): 345 - 353. [Abstract] [Full Text] |
||||
![]() |
P. Benoit, F. Emmanuel, J. M. Caillaud, L. Bassinet, G. Castro, P. Gallix, J. C. Fruchart, D. Branellec, P. Denefle, and N. Duverger Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models Circulation, January 12, 1999; 99(1): 105 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chiesa, C. Parolini, M. Canavesi, N. Colombo, C. R. Sirtori, R. Fumagalli, G. Franceschini, and F. Bernini Human Apolipoproteins A-I and A-II in Cell Cholesterol Efflux : Studies With Transgenic Mice Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1417 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Chung, F. Franklin, B. H. S. Cho, J. P. Segrest, K. Hart, and B. E. Darnell Potencies of Lipoproteins in Fasting and Postprandial Plasma to Accept Additional Cholesterol Molecules Released From Cell Membranes Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1217 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, S. Bellosta, C. Langer, F. Bernini, R. E. Pitas, R. W. Mahley, G. Assmann, and A. von Eckardstein Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma PNAS, June 23, 1998; 95(13): 7585 - 7590. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jian, M. de la Llera-Moya, Y. Ji, N. Wang, M. C. Phillips, J. B. Swaney, A. R. Tall, and G. H. Rothblat Scavenger Receptor Class B Type I as a Mediator of Cellular Cholesterol Efflux to Lipoproteins and Phospholipid Acceptors J. Biol. Chem., March 6, 1998; 273(10): 5599 - 5606. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Shah, J. Nilsson, S. Kaul, M. C. Fishbein, H. Ageland, A. Hamsten, J. Johansson, F. Karpe, and B. Cercek Effects of Recombinant Apolipoprotein A-IMilano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice Circulation, March 3, 1998; 97(8): 780 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fournier, J.-L. Paul, V. Atger, A. Cogny, T. Soni, M. de la Llera-Moya, G. Rothblat, and N. Moatti HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2685 - 2691. [Abstract] [Full Text] |
||||
![]() |
B. Igau, G. Castro, V. Clavey, C. Slomianny, R. Bresson, P. Drouin, J.-C. Fruchart, and C. Fievet In Vivo Glucosylated LpA-I Subfraction : Evidence for Structural and Functional Alterations Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2830 - 2836. [Abstract] [Full Text] |
||||
![]() |
B. F. Asztalos, M. Lefevre, T. A. Foster, R. Tulley, M. Windhauser, L. Wong, and P. S. Roheim Normolipidemic Subjects With Low HDL Cholesterol Levels Have Altered HDL Subpopulations Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1885 - 1893. [Abstract] [Full Text] |
||||
![]() |
Y. Ji, B. Jian, N. Wang, Y. Sun, M. d. l. L. Moya, M. C. Phillips, G. H. Rothblat, J. B. Swaney, and A. R. Tall Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux J. Biol. Chem., August 22, 1997; 272(34): 20982 - 20985. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jaspard, N. Fournier, G. Vieitez, V. Atger, R. Barbaras, C. Vieu, J. Manent, H. Chap, B. Perret, and X. Collet Structural and Functional Comparison of HDL From Homologous Human Plasma and Follicular Fluid : A Model for Extravascular Fluid Arterioscler Thromb Vasc Biol, August 1, 1997; 17(8): 1605 - 1613. [Abstract] [Full Text] |
||||
![]() |
H. Mezdour, R. Jones, C. Dengremont, G. Castro, and N. Maeda Hepatic Lipase Deficiency Increases Plasma Cholesterol but Reduces Susceptibility to Atherosclerosis in Apolipoprotein E-deficient Mice J. Biol. Chem., May 23, 1997; 272(21): 13570 - 13575. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. V. Rodrigueza, K. J. Williams, G. H. Rothblat, and M. C. Phillips Remodeling and Shuttling: Mechanisms for the Synergistic Effects Between Different Acceptor Particles in the Mobilization of Cellular Cholesterol Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 383 - 393. [Abstract] [Full Text] |
||||
![]() |
N. Duverger, C. Viglietta, L. Berthou, F. Emmanuel, A. Tailleux, L. Parmentier-Nihoul, B. Laine, C. Fievet, G. Castro, J. C. Fruchart, et al. Transgenic Rabbits Expressing Human Apolipoprotein A-I in the Liver Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1424 - 1429. [Abstract] [Full Text] |
||||
![]() |
S. Seguret-Mace, M. Latta-Mahieu, G. Castro, G. Luc, J.-C. Fruchart, E. Rubin, P. Denefle, and N. Duverger Potential Gene Therapy for Lecithin-Cholesterol Acyltransferase (LCAT)–Deficient and Hypoalphalipoproteinemic Patients With Adenovirus-Mediated Transfer of Human LCAT Gene Circulation, November 1, 1996; 94(9): 2177 - 2184. [Abstract] [Full Text] |
||||
![]() |
N. Duverger, H. Kruth, F. Emmanuel, J.-M. Caillaud, C. Viglietta, G. Castro, A. Tailleux, C. Fievet, J. C. Fruchart, L. M. Houdebine, et al. Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic Rabbits Circulation, August 15, 1996; 94(4): 713 - 717. [Abstract] [Full Text] |
||||
![]() |
Y. Huang, A. von Eckardstein, S. Wu, and G. Assmann Cholesterol Efflux, Cholesterol Esterification, and Cholesteryl Ester Transfer by LpA-I and LpA-I/A-II in Native Plasma Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1412 - 1418. [Abstract] [Full Text] |
||||
![]() |
E. P. C. Kilsdonk, P. G. Yancey, G. W. Stoudt, F. W. Bangerter, W. J. Johnson, M. C. Phillips, and G. H. Rothblat Cellular Cholesterol Efflux Mediated by Cyclodextrins J. Biol. Chem., July 21, 1995; 270(29): 17250 - 17256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohta, K. Saku, K. Takata, R. Nakamura, Y. Ikeda, and I. Matsuda Different Effects of Subclasses of HDL Containing ApoA-I but Not ApoA-II (LpA-I) on Cholesterol Esterification in Plasma and Net Cholesterol Efflux From Foam Cells Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 956 - 962. [Abstract] [Full Text] |
||||
![]() |
L. Lagrost, C. Dengremont, A. Athias, C. d. Geitere, J.-C. Fruchart, C. Lallemant, P. Gambert, and G. Castro Modulation of Cholesterol Efflux from Fu5AH Hepatoma Cells by the Apolipoprotein Content of High Density Lipoprotein Particles J. Biol. Chem., June 2, 1995; 270(22): 13004 - 13009. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fournier, A. Cogny, V. Atger, D. Pastier, D. Goudouneche, A. Nicoletti, N. Moatti, J. Chambaz, J.-L. Paul, and A.-D. Kalopissis Opposite Effects of Plasma From Human Apolipoprotein A-II Transgenic Mice on Cholesterol Efflux From J774 Macrophages and Fu5AH Hepatoma Cells Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 638 - 643. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |